Icon Wealth Partners, LLC Vertex Pharmaceuticals Inc Transaction History

Icon Wealth Partners, LLC

$878 Million
Q3 2023

A detailed history of Icon Wealth Partners, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Icon Wealth Partners, LLC holds 2,497 shares of VRTX stock, worth $991,983. This represents 0.1% of its overall portfolio holdings.

Number of Shares

2,497

Previous 2,535 1.5%

Holding current value

$991,983

Previous $892,000 2.69%

% of portfolio

0.1%

Previous 0.09%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$338.18 - $362.46 $12,850 - $13,773	-38 Reduced 1.5%	2,497 $868,000
Q2 2023 Aug 03, 2023	SELL	$314.42 - $351.91 $78,605 - $87,977	-250 Reduced 8.98%	2,535 $892,000
Q1 2023 May 11, 2023	SELL	$283.23 - $323.1 $111,592 - $127,301	-394 Reduced 12.39%	2,785 $877,000
Q2 2022 Jul 19, 2022	SELL	$234.96 - $292.55 $153,663 - $191,327	-654 Reduced 17.06%	3,179 $896,000
Q1 2022 Apr 19, 2022	SELL	$221.42 - $260.97 $213,891 - $252,097	-966 Reduced 20.13%	3,833 $1 Million
Q4 2021 Jan 19, 2022	SELL	$177.01 - $223.45 $24,958 - $31,506	-141 Reduced 2.85%	4,799 $1.05 Million
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $203,700 - $227,957	1,123 Added 29.42%	4,940 $896,000
Q2 2021 Jul 30, 2021	BUY	$187.49 - $221.1 $25,686 - $30,290	137 Added 3.72%	3,817 $770,000
Q1 2021 Apr 26, 2021	BUY	$207.02 - $241.31 $163,131 - $190,152	788 Added 27.25%	3,680 $791,000
Q4 2020 Feb 08, 2021	BUY	$207.01 - $276.09 $114,269 - $152,401	552 Added 23.59%	2,892 $683,000
Q3 2020 Oct 22, 2020	SELL	$255.65 - $303.1 $114,019 - $135,182	-446 Reduced 16.01%	2,340 $636,000
Q2 2020 Jul 14, 2020	BUY	$225.48 - $295.8 $286,810 - $376,257	1,272 Added 84.02%	2,786 $809,000
Q1 2020 Apr 17, 2020	SELL	$199.77 - $247.81 $27,768 - $34,445	-139 Reduced 8.41%	1,514 $360,000
Q4 2019 Jan 29, 2020	SELL	$166.71 - $223.91 $33,675 - $45,229	-202 Reduced 10.89%	1,653 $362,000
Q3 2019 Oct 24, 2019	SELL	$166.23 - $187.09 $1,662 - $1,870	-10 Reduced 0.54%	1,855 $314,000
Q2 2019 Aug 13, 2019	BUY	$164.61 - $190.37 $53,004 - $61,299	322 Added 20.87%	1,865 $342,000
Q1 2019 May 09, 2019	SELL	$163.73 - $194.7 $52,229 - $62,109	-319 Reduced 17.13%	1,543 $284,000
Q4 2018 Feb 14, 2019	SELL	$151.91 - $192.21 $1,822 - $2,306	-12 Reduced 0.64%	1,862 $309,000
Q3 2018 Nov 14, 2018	SELL	$167.73 - $192.74 $24,320 - $27,947	-145 Reduced 7.18%	1,874 $361,000
Q2 2018 Aug 13, 2018	SELL	$145.72 - $169.96 $140,474 - $163,841	-964 Reduced 32.32%	2,019 $343,000
Q1 2018 May 15, 2018	SELL	$151.6 - $177.13 $80,196 - $93,701	-529 Reduced 15.06%	2,983 $486,000
Q4 2017 Feb 13, 2018	BUY	$137.28 - $155.55 $482,127 - $546,291	3,512	3,512 $526,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $102B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Icon Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Icon Wealth Partners, LLC with notifications on news.

Account

Icon Wealth Partners, LLC Vertex Pharmaceuticals Inc Transaction History